MRGPRX4 is a bile acid receptor for human cholestatic itch

Patients with liver diseases often suffer from chronic itch, yet the pruritogen(s) and receptor(s) remain largely elusive. Here, we identify bile acids as natural ligands for MRGPRX4. MRGPRX4 is expressed in human dorsal root ganglion (hDRG) neurons and co-expresses with itch receptor HRH1. Bile aci...

Full description

Saved in:
Bibliographic Details
Published in:eLife Vol. 8
Main Authors: Yu, Huasheng, Zhao, Tianjun, Liu, Simin, Wu, Qinxue, Johnson, Omar, Wu, Zhaofa, Zhuang, Zihao, Shi, Yaocheng, Peng, Luxin, He, Renxi, Yang, Yong, Sun, Jianjun, Wang, Xiaoqun, Xu, Haifeng, Zeng, Zheng, Zou, Peng, Lei, Xiaoguang, Luo, Wenqin, Li, Yulong
Format: Journal Article
Language:English
Published: England eLife Science Publications, Ltd 10-09-2019
eLife Sciences Publications Ltd
eLife Sciences Publications, Ltd
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Patients with liver diseases often suffer from chronic itch, yet the pruritogen(s) and receptor(s) remain largely elusive. Here, we identify bile acids as natural ligands for MRGPRX4. MRGPRX4 is expressed in human dorsal root ganglion (hDRG) neurons and co-expresses with itch receptor HRH1. Bile acids elicited Ca responses in cultured hDRG neurons, and bile acids or a MRGPRX4 specific agonist induced itch in human subjects. However, a specific agonist for another bile acid receptor TGR5 failed to induce itch in human subjects and we find that human TGR5 is not expressed in hDRG neurons. Finally, we show positive correlation between cholestatic itch and plasma bile acids level in itchy patients and the elevated bile acids is sufficient to activate MRGPRX4. Taken together, our data strongly suggest that MRGPRX4 is a novel bile acid receptor that likely underlies cholestatic itch in human, providing a promising new drug target for anti-itch therapies.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2050-084X
2050-084X
DOI:10.7554/elife.48431